Federal Supply Schedule 36F79726D001E
Award Date 11/1/25
Last Date to Order 4/30/26
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Valinor Pharma, LLC, a for-profit limited liability company. The contract is a multiple award, non-set-aside agreement with a ceiling value of $25,000.00 and a period of performance through October 17, 2023. The contract is an "Interim Agreement" issued under Federal Supply Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related...
- This Federal Supply Schedule contract awards Intra-Cellular Therapies, Inc. (UEI: VA5JXLCJHDK7) a multiple-award indefinite delivery vehicle for the procurement of drugs, pharmaceuticals, and hematology-related products under General Services Administration Schedule 61-IB (Pharmaceuticals and Drugs). The contract was awarded on October 1, 2020, with an ultimate completion date of September 30, 2026, and carries a ceiling value of $24,000,000. The Veterans Integrated Service Network 12, a...
- The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
- This Federal Supply Schedule contract awards $225,000 to Lnhc, Inc. (UEI: FQH4VQBH5SZ7) under a multiple-award vehicle for the provision of drugs, pharmaceuticals, and hematology-related products classified under Federal Supply Group 65 I B. The contract was awarded on November 1, 2025, with an ultimate completion date of October 31, 2030, providing a five-year period of performance. The contracting agency is the Veterans Integrated Service Network 12, a civilian component of the Department of...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Springworks Therapeutics, Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through April 14, 2024. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows government agencies to procure these...
- The Federal Supply Schedule contract award referenced is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSS Contract 65 I B) by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 12. The prime contractor is Haleon US LP, a for-profit manufacturer of goods. The contract has a total ceiling value of $9,867,650.00 and a period of performance extending through September 30, 2026. This is a multiple award schedule contract, meaning it...
- The Federal Supply Schedule contract is a multiple award, $300,000 indefinite delivery vehicle (IDV) awarded by the Department of Veterans Affairs (VA) to Liquidia Technologies, Inc. The contract is for 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance from September 15, 2025 to September 14, 2030. The purpose of this contract is to provide the VA with a range of pharmaceutical and related hematology products. As a Federal Supply Schedule contract,...
- The provided information describes a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Verona Pharma, Inc. The contract, with an ID of 36F79724D053E, is for the procurement of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple-award contract with a period of performance through March 14, 2025 and a ceiling value of $25,000.00. As a Federal Supply Schedule contract, this agreement establishes...
- This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
- The Federal Supply Schedule (FSS) contract in question was awarded by the Veterans Integrated Service Network 12, a civilian agency, to Zyla Life Sciences US, LLC (doing business as Egalet Corp Delaware) on July 15, 2025. The contract is set to expire on July 14, 2030, with a ceiling value of $13,243,650.00. The purpose of this FSS contract is to provide the government with Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Schedule. The...